TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook

Oxid Med Cell Longev. 2022 Apr 11:2022:7805115. doi: 10.1155/2022/7805115. eCollection 2022.

Abstract

Thioredoxin-interacting protein (TXNIP) was originally named vitamin D3 upregulated protein-1 (VDUP1) because of its ability to bind to thioredoxin (TRX) and inhibit TRX function and expression. TXNIP is an alpha-arrestin protein that is essential for redox homeostasis in the human body. TXNIP may act as a double-edged sword in the cell. The balance of TXNIP is crucial. A study has shown that TXNIP can travel between diverse intracellular locations and bind to different proteins to play different roles under oxidative stress. The primary function of TXNIP is to induce apoptosis or pyroptosis under oxidative stress. TXNIP also inhibits proliferation and migration in cancer cells, although TXNIP levels decrease, and function diminishes in various cancers. In this review, we summarized the main structure, binding proteins, pathways, and the role of TXNIP in diseases, aiming to explore the double-edged sword role of TXNIP, and expect it to be helpful for future treatment using TXNIP as a therapeutic target.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Carrier Proteins / metabolism
  • Humans
  • Neoplasms* / drug therapy
  • Oxidation-Reduction
  • Oxidative Stress
  • Thioredoxins* / metabolism

Substances

  • Carrier Proteins
  • TXNIP protein, human
  • Thioredoxins